Cecilie Blimark

2.7k total citations
39 papers, 1.5k citations indexed

About

Cecilie Blimark is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Cecilie Blimark has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 19 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Cecilie Blimark's work include Multiple Myeloma Research and Treatments (35 papers), Peptidase Inhibition and Analysis (11 papers) and Protein Degradation and Inhibitors (10 papers). Cecilie Blimark is often cited by papers focused on Multiple Myeloma Research and Treatments (35 papers), Peptidase Inhibition and Analysis (11 papers) and Protein Degradation and Inhibitors (10 papers). Cecilie Blimark collaborates with scholars based in Sweden, United States and Iceland. Cecilie Blimark's co-authors include Ingemar Turesson, Magnus Björkholm, Sigurður Y. Kristinsson, Ulf‐Henrik Mellqvist, Ola Landgren, Anders Wåhlin, Lynn R. Goldin, Erik Holmberg, Ola Landgren and Ruth M. Pfeiffer and has published in prestigious journals such as New England Journal of Medicine, Blood and International Journal of Cancer.

In The Last Decade

Cecilie Blimark

37 papers receiving 1.4k citations

Peers

Cecilie Blimark

HEMAT

ONCOL

GENET

IMMUN

Naoki Takezako Japan

Masamitsu Yanada Japan

Ibrahim Aldoss United States

Okke de Weerdt Netherlands

Hyun‐Sook Chi South Korea

Emmanuelle Tavernier France

Po‐Nan Wang Taiwan

J. Anthony Child United Kingdom

Mar Tormo Spain

David H. Vesole United States

Naoki Takezako Japan

Cecilie Blimark

1.2k ×1.1

HEMAT

734 ×1.3

843 ×1.6

ONCOL

315 ×0.8

GENET

356 ×1.9

IMMUN

Citations per year, relative to Cecilie Blimark Cecilie Blimark (= 1×) peers Naoki Takezako

Countries citing papers authored by Cecilie Blimark

Since Specialization

Citations

This map shows the geographic impact of Cecilie Blimark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilie Blimark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilie Blimark more than expected).

Fields of papers citing papers by Cecilie Blimark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilie Blimark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilie Blimark. The network helps show where Cecilie Blimark may publish in the future.

Co-authorship network of co-authors of Cecilie Blimark

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilie Blimark. A scholar is included among the top collaborators of Cecilie Blimark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilie Blimark. Cecilie Blimark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blimark, Cecilie, Kristina Carlson, Christopher Day, et al.. (2024). Risk of infections in multiple myeloma. A population-based study on 8672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry. Haematologica. 110(1). 163–172. 5 indexed citations

Einarsdottir, Sigrun, et al.. (2024). Respiratory syncytial virus and other vaccine-preventable infections in Multiple Myeloma. A population-based study on 8672 myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry. Haematologica. 110(1). 179–182. 1 indexed citations

Carlson, Kristina, et al.. (2023). Income and Education Affect Prognosis and Treatment in Symptomatic Myeloma: A Population-Based Study on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry. Blood. 142(Supplement 1). 4723–4723. 1 indexed citations

Blimark, Cecilie, Kristina Carlson, Christopher Day, et al.. (2023). Risk of Infections in Multiple Myeloma in the Era of Novel Agents, a Population-Based Study Based on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry. Blood. 142(Supplement 1). 4696–4696.

Turesson, Ingemar, Anna Genell, Tobias Wirenfeldt Klausen, et al.. (2022). Improved survival in myeloma patients–a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden. Haematologica. 108(6). 1640–1651. 8 indexed citations

Blimark, Cecilie, Annette Juul Vangsted, Tobias Wirenfeldt Klausen, et al.. (2021). Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries. European Journal Of Haematology. 108(2). 99–108. 11 indexed citations

Wålinder, Göran, Jan Samuelsson, Per Näsman, et al.. (2019). Outcome and characteristics of non‐measurable myeloma: A cohort study with population‐based data from the Swedish Myeloma Registry. European Journal Of Haematology. 104(5). 376–382. 5 indexed citations

Falk, Ingrid Jakobsen, Johan Lund, Henrik Gréen, et al.. (2017). Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial. Cancer Chemotherapy and Pharmacology. 81(1). 183–193. 12 indexed citations

Blimark, Cecilie, Ingemar Turesson, Anna Genell, et al.. (2017). Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry. Haematologica. 103(3). 506–513. 97 indexed citations

10.

Nahi, Hareth, Anna Genell, Göran Wålinder, et al.. (2017). Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population‐based data from the Swedish Myeloma Register. European Journal Of Haematology. 99(3). 216–222. 38 indexed citations

11.

Blimark, Cecilie, Erik Holmberg, Ulf‐Henrik Mellqvist, et al.. (2014). Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 100(1). 107–113. 318 indexed citations

12.

Kristinsson, Sigurður Y., Erik Holmberg, & Cecilie Blimark. (2013). Treatment for high-risk smoldering myeloma.. New England Journal of Medicine. 369(18). 1762–1763. 34 indexed citations

13.

Kristinsson, Sigurður Y., Min Tang, Ruth M. Pfeiffer, et al.. (2011). Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study. Haematologica. 97(6). 854–858. 93 indexed citations

14.

Blimark, Cecilie, Ljupco Veskovski, Jan Westin, et al.. (2011). Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation. European Journal Of Haematology. 87(2). 117–122. 12 indexed citations

15.

Kristinsson, Sigurður Y., Min Tang, Ruth M. Pfeiffer, et al.. (2010). Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood. 116(15). 2651–2655. 73 indexed citations

16.

Landgren, Ola, Sigurður Y. Kristinsson, Lynn R. Goldin, et al.. (2009). Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood. 114(4). 791–795. 101 indexed citations

17.

Kristinsson, Sigurður Y., Magnus Björkholm, Lynn R. Goldin, et al.. (2009). Patterns of hematologic malignancies and solid tumors among 37,838 first‐degree relatives of 13,896 patients with multiple myeloma in Sweden. International Journal of Cancer. 125(9). 2147–2150. 55 indexed citations

18.

Kristinsson, Sigurður Y., Magnus Björkholm, Therése Andersson, et al.. (2009). Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica. 94(12). 1714–1720. 76 indexed citations

19.

Kristinsson, Sigurður Y., Ruth M. Pfeiffer, Magnus Björkholm, et al.. (2009). Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study.. Blood. 114(22). 1872–1872. 12 indexed citations

20.

Blimark, Cecilie, et al.. (2006). Percutaneous vertebroplasty at C2: case report of a patient with multiple myeloma and a literature review. European Spine Journal. 16(S3). 242–249. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact